Tevogen Bio Introduces Tevogen.ai To Enhance Patient Accessibility And Accelerate Innovation Leveraging Artificial Intelligence

Tevogen Bio Inc has launched Tevogen.ai, a ground-breaking effort that aims to employ artificial intelligence (AI) to transform numerous elements of the pharmaceutical sector, including medication research, development, manufacturing, distribution, and patient access. This program brings together a group of professionals, including research scientists, physicians, data scientists, and AI/machine learning engineers, who are committed to the ethical development and commercialization of AI-driven technologies that ease operations and improve health outcomes.

Ryan Saadi, MD, MPH, CEO of Tevogen Bio, stated that the debut of Tevogen.ai represents a tremendous leap in medical innovation. Tevogen Bio promises to achieve significant advances in healthcare by merging their knowledge in biotechnology with the powers of AI. They believe that tailored immunotherapies are the future of medicine and that creative commercial structures are required to fuel medical innovation in a post-pandemic society.

Tevogen Bio is led by a team of eminent scientists and experienced industry professionals with a track record in drug development and global product launches.

Read More - https://bit.ly/48LUxV8